<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63-pharmaceuticals-13-00464">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gautam</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gupta</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Timonen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Akimov</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Szwajda</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Jaiswal</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Turei</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer</article-title>
  <source>NPJ Syst. Biol. Appl.</source>
  <year>2019</year>
  <volume>5</volume>
  <fpage>20</fpage>
  <pub-id pub-id-type="doi">10.1038/s41540-019-0098-z</pub-id>
  <pub-id pub-id-type="pmid">31312514</pub-id>
 </element-citation>
</ref>
